Bioten Co., Ltd. (XKON:289170)
South Korea · Delayed Price · Currency is KRW 3,440.00
+160.00 (4.88%)
At close: Mar 27, 2026
Bioten Market Cap
Bioten has a market cap or net worth of 12.3 billion as of March 27, 2026. Its market cap has decreased by -34.72% in one year.
Market Cap
12.30B
Enterprise Value
n/a
Revenue
10.71B
Ranking
n/a
PE Ratio
10.46
Stock Price
3,440.00
Market Cap Chart
Since October 13, 2023, Bioten's market cap has decreased from 23.56B to 12.30B, a decrease of -47.78%. That is a compound annual growth rate of -23.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 12.30B | -3.37% |
| Dec 30, 2025 | 12.73B | -29.50% |
| Dec 30, 2024 | 18.06B | 65.39% |
| Dec 28, 2023 | 10.92B | -53.65% |
| Oct 13, 2023 | 23.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seoul Pharma | 32.47B |
| Daesung Microbiological Labs. | 32.03B |
| ChoA Pharmaceutical Co., LTD. | 28.01B |
| Pharmsville | 26.82B |
| Hurum | 25.99B |
| BIFIDO | 23.97B |
| Union Korea Pharm | 19.70B |
| WooGene B&G | 19.67B |